SAM
NVO

Stansberry Asset Management’s Novo Nordisk NVO Stock Holding History

Stansberry Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94,778
Closed -$6.54M – 154
2025
Q2 		$6.54M Buy
94,778
+87
+0.1% +$5.92K 0.71% 55
2025
Q1 		$6.58M Buy
94,691
+8,090
+9% +$668K 0.79% 48
2024
Q4 		$7.45M Buy
86,601
+24,178
+39% +$2.61M 0.97% 43
2024
Q3 		$7.43M Buy
62,423
+3,142
+5% +$419K 0.93% 43
2024
Q2 		$8.46M Buy
59,281
+7,219
+14% +$957K 1.11% 33
2024
Q1 		$6.68M Buy
52,062
+8,733
+20% +$1.04M 0.9% 41
2023
Q4 		$4.48M Sell
43,329
-3,571
-8% -$353K 0.74% 43
2023
Q3 		$4.27M Buy
46,900
+502
+1% +$44.2K 0.75% 46
2023
Q2 		$3.75M Buy
46,398
+2,518
+6% +$206K 0.69% 45
2023
Q1 		$3.49M Buy
43,880
+19,558
+80% +$1.39M 0.68% 46
2022
Q4 		$1.65M Buy
24,322
+4,382
+22% +$257K 0.34% 56
2022
Q3 		$994K Buy
19,940
+1,644
+9% +$88.1K 0.21% 69
2022
Q2 		$1.02M Sell
18,296
-558
-3% -$31K 0.22% 71
2022
Q1 		$1.05M Buy
18,854
+7,460
+65% +$383K 0.17% 77
2021
Q4 		$638K Buy
11,394
+3,094
+37% +$168K 0.1% 86
2021
Q3 		$398K Buy
8,300
+1,152
+16% +$55.7K 0.08% 82
2021
Q2 		$299K Buy
+7,148
New +$277K 0.07% 47

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stansberry Asset Management's NVO Position: Q3 2025 in Review

Stansberry Asset Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 94,778 shares — an estimated $6.54M sold.

Stansberry Asset Management first reported a position in NVO in Q2 2021 and held it in 17 quarters. The position peaked at $8.46M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Stansberry Asset Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Stansberry Asset Management sold 94,778 Novo Nordisk shares in Q3 2025, an estimated $6.54M.
  • Stansberry Asset Management first reported a position in Novo Nordisk in Q2 2021 and held it in 17 quarters.
  • Stansberry Asset Management's Novo Nordisk position peaked at $8.46M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Stansberry Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.